Helixor – a pharmaceutical company for integrative medicine
Helixor Heilmittel GmbH is an international company in the field of integrative oncology. Our focus is on manufacturing and distributing remedies from mistletoe (Viscum album) and Christmas rose (Helleborus niger). Our Mission: improving the quality of life of cancer patients.
Helixor, currently having 100 employees, was founded over 40 years ago and is owned by the non-profit foundation Stiftung HELIXOR. Any earnings not re-invested in the company flow into this foundation.
The company’s headquarter is in Rosenfeld, south of Stuttgart. All of our activities take place here: harvesting and processing the medicinal plants, research, marketing and distribution. Helixor is active internationally with affiliates in Canada, Brazil and, most recently, India, and also works with distribution partners and customers in over 20 countries around the world.
Helixor medicinal products are produced in a unique manufacturing process in line with GMP regulations. Continuous clinical and preclinical research, as well as cooperation with university hospitals, physicians and scientists, demonstrate the efficacy and safety of our products.
The white-berry mistletoe is the most commonly used – and most thoroughly tested – medical product in complementary oncology. To date, white-berry mistletoe’s effects on various malignant diseases have been researched and proven in over 150 clinical trials, 30 of which used Helixor products.
Today, a great number of people (physicians and patients) are seeking natural remedies and therapies in addition to conventional treatments. Helixor see themselves as an ambassador of integrative oncology acting as an interface between conventional and complementary medicine.